Teams

Sector
Stage
  • ARTS Surgical Inc.
    from University of Texas at Austin.

    Our solution is a state of the art steerable drilling technology and a novel implant  featuring advanced precision to ensure higher accuracy in complex orthopedics and neurosurgical procedures and improve patient outcomes.

    Read More
  • GeneVentiv Therapeutics, Inc.
    from University of North Carolina at Chapel Hill.

    GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.

    Read More
  • Lumaegis, Inc
    from University of Texas at Austin.

    Orion Therapeutics is a delivery platform-enabled RNA therapeutics company. We pair a proprietary lipid nanoparticle GENESYS™ delivery platform that entirely excludes ionizable cationic lipids with a vascular RNA therapy pipeline. Our safe,…

    Read More